JP2022534501A5 - - Google Patents
Info
- Publication number
- JP2022534501A5 JP2022534501A5 JP2021570378A JP2021570378A JP2022534501A5 JP 2022534501 A5 JP2022534501 A5 JP 2022534501A5 JP 2021570378 A JP2021570378 A JP 2021570378A JP 2021570378 A JP2021570378 A JP 2021570378A JP 2022534501 A5 JP2022534501 A5 JP 2022534501A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- unsubstituted
- compound according
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962854597P | 2019-05-30 | 2019-05-30 | |
| US62/854,597 | 2019-05-30 | ||
| PCT/US2020/034746 WO2020243199A1 (en) | 2019-05-30 | 2020-05-27 | Tricyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534501A JP2022534501A (ja) | 2022-08-01 |
| JP2022534501A5 true JP2022534501A5 (enExample) | 2023-05-30 |
Family
ID=73552666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570378A Pending JP2022534501A (ja) | 2019-05-30 | 2020-05-27 | 三環式化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11136321B2 (enExample) |
| EP (1) | EP3976618A4 (enExample) |
| JP (1) | JP2022534501A (enExample) |
| KR (1) | KR20220016177A (enExample) |
| CN (1) | CN113906029A (enExample) |
| AU (1) | AU2020282707B2 (enExample) |
| BR (1) | BR112021023967A2 (enExample) |
| CA (1) | CA3138938A1 (enExample) |
| CL (1) | CL2021003139A1 (enExample) |
| CO (1) | CO2021017202A2 (enExample) |
| EA (1) | EA202192760A1 (enExample) |
| IL (1) | IL287813A (enExample) |
| MA (1) | MA56058A (enExample) |
| MX (1) | MX2021014458A (enExample) |
| PE (1) | PE20220427A1 (enExample) |
| PH (1) | PH12021552953A1 (enExample) |
| SG (1) | SG11202113214QA (enExample) |
| TW (1) | TW202110845A (enExample) |
| WO (1) | WO2020243199A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220000874A1 (en) * | 2019-05-30 | 2022-01-06 | Aligos Therapeutics, Inc. | Tricyclic compounds |
| CN114222746B (zh) * | 2019-12-10 | 2024-08-02 | 上海翰森生物医药科技有限公司 | 含吡唑多环类衍生物抑制剂、其制备方法和应用 |
| GB202103704D0 (en) * | 2021-03-17 | 2021-04-28 | Pathios Therapeutics Ltd | Compounds |
| EP4251625A4 (en) * | 2020-11-24 | 2024-10-09 | Aligos Therapeutics, Inc. | Tricyclic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0701273D0 (en) | 2007-01-24 | 2007-02-28 | Angeletti P Ist Richerche Bio | New compounds |
| WO2008157273A1 (en) | 2007-06-14 | 2008-12-24 | Smithkline Beecham Corporation | Chemical compounds |
| WO2015065338A1 (en) | 2013-10-29 | 2015-05-07 | Medivir Ab | Quinazoline based respiratory syncytial virus inhibitors |
| AU2017231817B2 (en) | 2016-03-09 | 2021-02-25 | Emory University | Elimination of hepatitis B virus with antiviral agents |
| CN110066278B (zh) * | 2017-06-01 | 2021-06-08 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
-
2020
- 2020-05-27 AU AU2020282707A patent/AU2020282707B2/en not_active Expired - Fee Related
- 2020-05-27 JP JP2021570378A patent/JP2022534501A/ja active Pending
- 2020-05-27 CA CA3138938A patent/CA3138938A1/en active Pending
- 2020-05-27 CN CN202080040114.2A patent/CN113906029A/zh active Pending
- 2020-05-27 SG SG11202113214QA patent/SG11202113214QA/en unknown
- 2020-05-27 MX MX2021014458A patent/MX2021014458A/es unknown
- 2020-05-27 PH PH1/2021/552953A patent/PH12021552953A1/en unknown
- 2020-05-27 MA MA056058A patent/MA56058A/fr unknown
- 2020-05-27 PE PE2021001952A patent/PE20220427A1/es unknown
- 2020-05-27 US US16/885,128 patent/US11136321B2/en active Active
- 2020-05-27 KR KR1020217042967A patent/KR20220016177A/ko not_active Ceased
- 2020-05-27 WO PCT/US2020/034746 patent/WO2020243199A1/en not_active Ceased
- 2020-05-27 EA EA202192760A patent/EA202192760A1/ru unknown
- 2020-05-27 BR BR112021023967A patent/BR112021023967A2/pt not_active IP Right Cessation
- 2020-05-27 EP EP20812759.7A patent/EP3976618A4/en not_active Withdrawn
- 2020-05-29 TW TW109118090A patent/TW202110845A/zh unknown
-
2021
- 2021-11-03 IL IL287813A patent/IL287813A/en unknown
- 2021-11-25 CL CL2021003139A patent/CL2021003139A1/es unknown
- 2021-12-15 CO CONC2021/0017202A patent/CO2021017202A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529466A5 (enExample) | ||
| EP1667694B1 (en) | Tlr7 ligands for the treatment of hepatitis c | |
| EP2997019B1 (en) | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | |
| KR102666477B1 (ko) | 글루타민 유사체의 프로드럭 | |
| US11001564B2 (en) | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same | |
| AU2016287472B2 (en) | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| ES2989915T3 (es) | Compuestos macrocíclicos como agonistas de STING y métodos y usos de los mismos | |
| EP3759083B1 (en) | 2,4-diaminoquinazoline derivatives and use thereof in the treatment of virus infections, cancer or allergies | |
| JP2010514768A5 (enExample) | ||
| RU2006109491A (ru) | Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств | |
| CA2422378A1 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
| JP2005508933A5 (enExample) | ||
| US9663487B2 (en) | Phosphoinositide 3-kinase inhibitors | |
| JP2022550454A5 (enExample) | ||
| SK4742001A3 (en) | Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection | |
| WO2008056264A3 (en) | Novel nucleotide analogues as percursor molecules for antivirals | |
| RU2007118729A (ru) | Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а | |
| JP2022519764A5 (enExample) | ||
| US20190169185A1 (en) | Substituted 2-n-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same | |
| ES2962269T3 (es) | Análogos de nucleósidos alquinil como inhibidores del rinovirus humano | |
| ZA200601632B (en) | Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus | |
| JP2004182725A5 (enExample) | ||
| AU2017335205A1 (en) | Pyrimidine prodrugs for the treatment of viral infections and further diseases | |
| WO2025207435A1 (en) | 2'-fluoro-6'-methylene carbocyclic nucleos(t)ides as potent antiviral agents for the treatment of wild-type and mutant hepatitis b virus (hbv) infections | |
| EP4686470A1 (en) | Macrocyclic peptidomimetics as antiviral agents |